Updated:
Anatomage
Jack Choi's Anatomage digitizes real human cadavers into 3D anatomy tables used by 4,000+ institutions. Santa Clara-based, with global offices.
Anatomage
Anatomage launched in 2004 under founder and CEO Jack Choi, a Carnegie Mellon-trained engineer with deep expertise in 3D imaging and medical device design. Though the firm's capital structure and backing are not publicly disclosed, Choi's dual role as inventor and controlling executive suggests concentrated ownership and a long product-development cycle uncommon among VC-dependent hardware companies. The firm's core asset is a proprietary library of digitized human cadavers, built from real frozen donor slices. These Anatomage Bodies populate a hardware-and-software ecosystem centered on the Anatomage Table — a life-size touchscreen dissection platform — and extend to tablet-based Anatomage Lessons and a Science Table for virtual lab experiments. Anatomage's deployment spans direct sales to medical schools, undergraduate healthcare programs, and a growing K–12 footprint, with additional revenue from veterinary education through Anatomage Table Vet. Confirmed product lines include InVivo surgical planning software, custom surgical guides, and Immersive Theater, but the firm does not publicly break out revenue, margins, or capital deployment figures. Anatomage employs more than 200 people across four offices: its Santa Clara headquarters and subsidiaries in Tokyo, Seoul, and Milan. The firm's products are in use at over 4,000 institutions globally. In August 2023, Anatomage added a geriatric cadaver sourced from a lung-cancer patient to its digital library — an expansion of its pathology and anatomical-variation catalog. The firm also runs an annual Anatomage Tournament, which brings together hundreds of students for anatomy competitions, reinforcing institutional stickiness. Anatomage's structural differentiator is its closed-loop digitization process. Unlike competitors that license or model anatomy from reference imagery, Anatomage converts real human donor tissue into interactive digital twins — controlling the full stack from cadaver acquisition to medical education distribution. This yields a regulated, defensible dataset that is difficult to replicate and positions the firm as a supplier to, rather than a competitor of, large hospital systems and device manufacturers.
General information
Firm type
Single Family Office
Year founded
2004
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Santa Clara
Corporate office
3350 Thomas Rd STE 150, Santa Clara, CA 95054, United States
Additional offices
Milan, Italy · Tokyo, Japan · Seoul, South Korea
Principals
Jack Choi
Founder and CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Anatomage?
Anatomage is founder-led and does not publicly disclose a separate investment committee or allocator function. Jack Choi serves as CEO and appears to control both product direction and capital strategy. There is no indication of external fund managers or a family office CIO structure.
How does Anatomage source and build its digital cadaver IP?
The firm sources real human donor bodies and digitizes them through a proprietary process that converts frozen cadaveric slices into interactive 3D models. This pipeline — from cadaver acquisition to functional simulation — is developed entirely in-house. Anatomage does not license its core anatomy data from external libraries.
Is Anatomage a single family office or a medical-device company?
Anatomage operates as a commercial medical-visualization company selling hardware and software to educational and healthcare institutions. The label 'family office' would be inaccurate: it generates revenue from product sales, not from managing a family's invested wealth. Its capital structure and ownership are private and undisclosed, but its public-facing operations are those of a global med-tech vendor.
Does Anatomage participate in fund commitments or direct venture investments?
There is no public record of Anatomage making fund commitments or venture investments. The firm's retained earnings appear to be reinvested into product development, geographic expansion, and the ongoing digitization of new cadaver specimens.
What is the known geographic footprint of Anatomage beyond the US?
Anatomage maintains subsidiary offices in Tokyo, Seoul, and Milan, and its products are used in over 4,000 institutions globally. The firm runs regional student tournaments and local webinars, indicating a direct sales and support presence in Asia and Europe.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: